IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells

Luisa Cironi1, Nicolò Riggi, Paolo Provero

  • 1Division of Experimental Pathology, Institute of Pathology CHUV, University of Lausanne, Lausanne, Switzerland.

Plos One
|July 24, 2008
PubMed
Abstract

Insights

Ewing

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ewing's sarcoma family tumors (ESFT) are primarily driven by EWS-FLI-1 fusion proteins, with other chimeric genes implicated in a minority of cases.
  • ESFT growth and survival are critically dependent on insulin-like growth factor-1 (IGF-1).
  • Mesenchymal progenitor/stem cells are a potential cell of origin for ESFT.

Purpose of the Study:

  • To investigate the functional relationships among different ESFT-associated fusion proteins.
  • To compare the ability of mouse progenitor cells (MPCs) to express various ESFT fusion proteins.
  • To analyze the gene expression changes induced by these fusion proteins and identify common mechanisms in ESFT pathogenesis.

Main Methods:

  • Assessed mouse progenitor cell (MPC) permissiveness for expressing EWS-FLI-1, EWS-ERG, and FUS-ERG fusion proteins.
  • Analyzed gene expression profile changes in MPCs following expression of the fusion proteins.
  • Investigated the activation of the IGF1 promoter and IGF1 expression by the fusion proteins.

Main Results:

  • MPC isolates showed variable permissiveness for expressing EWS-FLI-1, EWS-ERG, and FUS-ERG.
  • Transcriptome changes induced by the fusion proteins exhibited limited overlap.
  • All three ESFT fusion proteins, but not FLI-1 or ERG-1 alone, activated the IGF1 promoter and induced IGF1 expression.

Conclusions:

  • Different ESFT-associated fusion proteins may require distinct cellular environments and induce unique transcriptome alterations.
  • IGF1 induction represents a potential common mechanism by which these fusion proteins contribute to ESFT development.
  • Understanding these mechanisms can inform targeted therapeutic strategies for ESFT.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...